Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Use of Leishmania major parasites expressing a recombinant Trypanosoma cruzi antigen as live vaccines against Chagas disease

Frontiers in Microbiology(2022)10.3389/fmicb.2022.1059115Source: DataRank Database

Use of Leishmania major parasites expressing a recombinant Trypanosoma cruzi antigen as live vaccines against Chagas disease is a research paper published in Frontiers in Microbiology (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.44)OA: goldTopics (30)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Anne E. O’Shea ORCID,Christopher S. Eickhoff ORCID,Hongjie Guo ORCID,Warren G. Lewis ORCID,Stephen M. Beverley ORCID

Live enrichment

PubMed:36523834 PMC:PMC9745109 OpenAlex:https://openalex.org/W4310988543

NIAID NIH HHS

Grant: R01 AI029646

National Institutes of Health

Grant: 5R01AI031078-09

GLYCOSYLATION MUTANTS OF LEISHMANIA

National Institutes of Health

Grant: 5R01AI029646-07

MOLECULAR GENETICS OF LEISHMANIA

National Institutes of Health

Grant: 5R21AI128270-02

Protective and pathologic effects of Th17 cells specific for an intracellular pathogen

FWCI

0.44

Citation Percentile

0.6%

Citation Trend

2023

2024

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fmicb.2022.1059115/pdf

GOLDhttps://www.frontiersin.org/articles/10.3389/fmicb.2022.1059115/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fmicb.2022.1059115/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fmicb.2022.1059115/full

journalhttps://doi.org/10.3389/fmicb.2022.1059115

Fields of Study

Trypanosoma species research and implicationsResearch on Leishmaniasis StudiesSynthesis and Biological EvaluationMedicineBiology0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Trypanosoma cruziChagas diseaseVirologyBiologyLeishmaniaAntigenImmunityRecombinant DNAMicrobiologyVaccinationVirulenceImmunologyImmune systemParasite hostingVaccineParasiteLeishmaniasisLive VectorChagasICTS (Institute of Clinical and Translational Sciences)Medicine and Health SciencesQR1-502

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being